EMA Withdrawn: Palonosetron Hospira (palonosetron hydrochloride) — Pfizer Europe MA EEIG

View source ↗

Summary

Palonosetron Hospira (palonosetron hydrochloride) has been withdrawn in the EMA system.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Nausea
• Vomiting

Drugs mentioned

• Palonosetron Hospira (palonosetron hydrochloride)

Snippet

Status: Withdrawn. Therapeutic area: Nausea;Vomiting;Cancer. MAH: Pfizer Europe MA EEIG. Decision date: 12/12/2018